The protocol at a glance
The Russian label says 2 drops in each nostril, 3 times a day, for 14 days. A doctor can repeat the course after 1 to 3 weeks.
| Item | Russian label (0.15% nasal drops) |
|---|---|
| Strength | 1.5 mg per mL |
| Dose | 2 drops in each nostril, 3 times a day (12 drops a day) |
| Course | 14 days |
| Repeat | After 1 to 3 weeks, with a doctor |
| Drop size | Not stated on the label |
From the Russian drug reference RLS (Selank entry, Peptogen, registration number ЛП-№(010951)-(РГ-RU)). Nasal use only. The label does not give a daily amount in mcg.
Community notes report 200 to 400 mcg two to three times a day (400 mcg to 1.2 mg a day), 2 weeks on, mostly nasal. These are user reports, not trial data.
What people say they do, collected from community discussions. Not tested in a trial; shown so you can compare it with the evidence above.
Mixing
No mixing table here: this one is used as a capsule, nasal spray or skin product, or has no human amount to calculate from. The general mixing calculator works for any vial.
What the trials found
Small Russian studies in anxiety, compared with older anxiety drugs. The abstracts do not give effect sizes. I found no placebo-controlled trial.
Zozulia AA et al. 2008 (PMID 18454096); Medvedev VE et al. 2014 (PMID 25176261) and 2015 (PMID 26356395). All in Zh Nevrol Psikhiatr Im S S Korsakova, Russian-language papers.
Side effects
- The label lists allergic reactions, including delayed ones, and an unpleasant taste when the drops run down the throat.
- The label says not to use it in pregnancy, breastfeeding or under age 18.
- I found no large trial that measured safety.
How it works
Enkephalin breakdown
In blood samples, Selank slowed the enzymes that break down enkephalins, which are natural calming peptides.
Tuftsin analog
It is built from tuftsin (Thr-Lys-Pro-Arg) with Pro-Gly-Pro added. In rats it changed BDNF levels in memory-related brain areas.
Sources
- RLS (rlsnet.ru) Selank 0.15% nasal drops entry, Peptogen
- Zozulia AA et al. Zh Nevrol Psikhiatr 2008;108(4):38-48, PMID 18454096
- Medvedev VE et al. Zh Nevrol Psikhiatr 2014;114(7):17-22, PMID 25176261
- Medvedev VE et al. Zh Nevrol Psikhiatr 2015;115(6):33-40, PMID 26356395
- Enkephalin-degrading enzymes and Selank. Bull Exp Biol Med 2001, PMID 11550013
- Selank and ethanol-induced memory impairment in rats (BDNF). Bull Exp Biol Med 2019, PMID 31625062
- ClinicalTrials.gov search by intervention name, run 5 Nov 2026: no Selank peptide trials